Finance

Lists
Why is NXTG up 9.50%?
Dive Deeper
NXTG:TLV
Nextage Therapeutics Ltd
ILA 39.20
+9.50%
(+3.40) 1D
Sep 24, 5:26:00 PM GMT+3  ·   ILA
All symbols
SymbolPriceChange% Change
Generating top insights for NXTG...
Open
ILA 40.90
High
ILA 40.90
Low
ILA 35.00
Mkt. cap
37.19M
Avg. vol.
60.36K
Volume
115.06K
52-wk high
ILA 89.80
52-wk low
ILA 27.00
EPS
-ILA 0.07
Shares outstanding
94.86M
No. of employees
31
Open
ILA 40.90
High
ILA 40.90
Low
ILA 35.00
Mkt. cap
37.19M
Avg. vol.
60.36K
Volume
115.06K
52-wk high
ILA 89.80
52-wk low
ILA 27.00
EPS
-ILA 0.07
Shares outstanding
94.86M
No. of employees
31
About Nextage Therapeutics Ltd
CEO-
Employees31
Founded1982
Headquarters-
SectorBiotechnology
Previous reportsAll values in ILS
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in ILS
Mar 2025
Jun 2025
Mar 2026
Jun 2026
Revenue
677.00K
677.00K
134.00K
134.00K
Cost of goods sold
755.50K
755.50K
762.00K
762.00K
Cost of revenue
755.50K
755.50K
762.00K
762.00K
Research and development expenses
344.50K
344.50K
513.50K
513.50K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
940.00K
940.00K
2.30M
2.30M
Operating expense
1.28M
1.28M
2.81M
2.81M
Total operating expenses
2.04M
2.04M
3.57M
3.57M
Operating income
-1.36M
-1.36M
-3.44M
-3.44M
Other non operating income
-
-
-
-
EBT including unusual items
571.00K
571.00K
-4.28M
-4.28M
EBT excluding unusual items
-1.99M
-1.99M
-4.28M
-4.28M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
678.00K
678.00K
-4.21M
-4.21M
Net profit margin
100.15%
100.15%
-3,143.66%
-3,143.66%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-609.00K
-609.00K
-837.00K
-837.00K
Net interest expenses
-609.00K
-609.00K
-837.00K
-837.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.04M
-1.04M
-3.12M
-3.12M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps